| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/14/2002 | CA2421760A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421757A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421448A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421445A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421229A1 Vaccine against microbial pathogens |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421199A1 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421193A1 Hiv peptides, antigens, vaccine compositions,immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421183A1 Novel polypeptide and anti-hiv agent containing the same |
| 03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | CA2420225A1 Hla-a2.1 binding peptides and their uses |
| 03/14/2002 | CA2419601A1 The treatment of inflammatory disorders |
| 03/14/2002 | CA2419563A1 Chimeric antisense of arabinofuranose analogue and deoxyribose nucleotides |
| 03/14/2002 | CA2417258A1 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 03/14/2002 | CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | CA2416336A1 Multivalent neuraminidase inhibitor conjugates |
| 03/14/2002 | CA2412279A1 "pseudo"-native chemical ligation |
| 03/14/2002 | CA2412278A1 Polymer-modified synthetic proteins |
| 03/14/2002 | CA2412277A1 Synthetic erythropoiesis stimulating proteins |
| 03/13/2002 | EP1186656A1 Method for preparing or removal of circoviruses from biological material |
| 03/13/2002 | EP1186654A1 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 narine aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof |
| 03/13/2002 | EP1186617A1 Novel recombinant antibody, amino acid sequences of cdrs thereof and genes encoding the same |
| 03/13/2002 | EP1186607A1 Optically active pyrrolopyridazine compounds |
| 03/13/2002 | EP1186604A1 Benzazepine derivatives, process for the preparation of the same and uses thereof |
| 03/13/2002 | EP1186599A1 Novel processes for the preparation of substituted propenone derivatives |
| 03/13/2002 | EP1185948A1 Method for screening and producing compound libraries |
| 03/13/2002 | EP1185712A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185696A1 Antisense oligonucleotide modulation of human protein kinase c-delta expression |
| 03/13/2002 | EP1185694A1 49 human secreted proteins |
| 03/13/2002 | EP1185691A1 Neisseria genomic sequences and methods of their use |
| 03/13/2002 | EP1185662A2 Dna vaccines for pets and sport animals |
| 03/13/2002 | EP1185660A2 Porcine circovirus vaccine in recombinant poxvirus |
| 03/13/2002 | EP1185659A2 Dna pcv vaccine |
| 03/13/2002 | EP1185649A2 The myostatin gene promoter and inhibition of activation thereof |
| 03/13/2002 | EP1185618A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 03/13/2002 | EP1185615A2 Recombinant influenza viruses for vaccines and gene therapy |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | EP1185536A2 Hemisynthetic method and intermediates thereof |
| 03/13/2002 | EP1185528A1 Inhibitors of il-12 production |
| 03/13/2002 | EP1185517A1 Antibiotic prodrugs |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185302A2 Specifically targeted catalytic antagonists and uses thereof |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | EP1185295A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185273A1 Antifungal oral composition containing itraconazole and process for preparing same |
| 03/13/2002 | EP1185271A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185270A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185265A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185261A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP1185237A1 Synergistic antibacterial combination |
| 03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents |
| 03/13/2002 | CN1340046A β－丙氨酸衍生物 β- alanine derivatives |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances |
| 03/13/2002 | CN1339442A Schizophyllary tetrasaccharide cluster compound and its preparing method and use |
| 03/13/2002 | CN1339440A Process for producing super critical extracting caterpillar fungus deoxynucleoside |
| 03/13/2002 | CN1339320A AIDS vacuum and its preparing method and use |
| 03/13/2002 | CN1339319A Medicine for treating AIDS and its preparing method |
| 03/13/2002 | CN1339318A Method for treating AIDS and its preparing method |
| 03/13/2002 | CN1339308A Five-flower bactericidal medicine |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/13/2002 | CN1080562C Use of prostance derivatives and the combination with antibiotics in the treatment of bacterial infections |
| 03/12/2002 | US6356845 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) |
| 03/12/2002 | US6355789 Cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits |
| 03/12/2002 | US6355689 Antiinflammatory agents |
| 03/12/2002 | US6355684 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355658 Coumarin derivatives, methods of preparation and application as medicines |
| 03/12/2002 | US6355643 Enzyme inhibitors, ras genes and proteins |
| 03/12/2002 | US6355620 C-2 modified erythromycin derivatives |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355450 Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
| 03/12/2002 | US6355426 Methods for the characterization and selection of RNA target motifs that bind compounds of pharmaceutical use |
| 03/12/2002 | US6355411 Virulence-associated nucleic acid sequences and uses thereof |
| 03/12/2002 | US6355265 Over-coated chewing gum formulations |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355255 Streptococcal C5a peptidase vaccine |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355253 Bactericidal antibodies |
| 03/12/2002 | US6355252 Antiinflammatory agents |
| 03/12/2002 | US6355248 Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | CA2086438C Anti-herpes virus and cytomegalovirus oligomers |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |